First Time Loading...

Merck KGaA
XETRA:MRK

Watchlist Manager
Merck KGaA Logo
Merck KGaA
XETRA:MRK
Watchlist
Price: 146.75 EUR -0.31% Market Closed
Updated: Apr 18, 2024

Intrinsic Value

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. [ Read More ]

The intrinsic value of one MRK stock under the Base Case scenario is 146.43 EUR. Compared to the current market price of 146.75 EUR, Merck KGaA is Fairly Valued.

Key Points:
MRK Intrinsic Value
Base Case
146.43 EUR
Fairly Valued
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Merck KGaA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling MRK stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Merck KGaA

Provide an overview of the primary business activities
of Merck KGaA.

What unique competitive advantages
does Merck KGaA hold over its rivals?

What risks and challenges
does Merck KGaA face in the near future?

Summarize the latest earnings call
of Merck KGaA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Merck KGaA.

Provide P/S
for Merck KGaA.

Provide P/E
for Merck KGaA.

Provide P/OCF
for Merck KGaA.

Provide P/FCFE
for Merck KGaA.

Provide P/B
for Merck KGaA.

Provide EV/S
for Merck KGaA.

Provide EV/GP
for Merck KGaA.

Provide EV/EBITDA
for Merck KGaA.

Provide EV/EBIT
for Merck KGaA.

Provide EV/OCF
for Merck KGaA.

Provide EV/FCFF
for Merck KGaA.

Provide EV/IC
for Merck KGaA.

Show me price targets
for Merck KGaA made by professional analysts.

What are the Revenue projections
for Merck KGaA?

How accurate were the past Revenue estimates
for Merck KGaA?

What are the Net Income projections
for Merck KGaA?

How accurate were the past Net Income estimates
for Merck KGaA?

What are the EPS projections
for Merck KGaA?

How accurate were the past EPS estimates
for Merck KGaA?

What are the EBIT projections
for Merck KGaA?

How accurate were the past EBIT estimates
for Merck KGaA?

Compare the revenue forecasts
for Merck KGaA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Merck KGaA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Merck KGaA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Merck KGaA compared to its peers.

Compare the P/E ratios
of Merck KGaA against its peers.

Discuss the investment returns and shareholder value creation
comparing Merck KGaA with its peers.

Analyze the financial leverage
of Merck KGaA compared to its main competitors.

Show all profitability ratios
for Merck KGaA.

Provide ROE
for Merck KGaA.

Provide ROA
for Merck KGaA.

Provide ROIC
for Merck KGaA.

Provide ROCE
for Merck KGaA.

Provide Gross Margin
for Merck KGaA.

Provide Operating Margin
for Merck KGaA.

Provide Net Margin
for Merck KGaA.

Provide FCF Margin
for Merck KGaA.

Show all solvency ratios
for Merck KGaA.

Provide D/E Ratio
for Merck KGaA.

Provide D/A Ratio
for Merck KGaA.

Provide Interest Coverage Ratio
for Merck KGaA.

Provide Altman Z-Score Ratio
for Merck KGaA.

Provide Quick Ratio
for Merck KGaA.

Provide Current Ratio
for Merck KGaA.

Provide Cash Ratio
for Merck KGaA.

What is the historical Revenue growth
over the last 5 years for Merck KGaA?

What is the historical Net Income growth
over the last 5 years for Merck KGaA?

What is the current Free Cash Flow
of Merck KGaA?

Financials

Balance Sheet Decomposition
Merck KGaA

Current Assets 12.4B
Cash & Short-Term Investments 2.5B
Receivables 4.6B
Other Current Assets 5.3B
Non-Current Assets 36.1B
Long-Term Investments 984m
PP&E 9.1B
Intangibles 24.4B
Other Non-Current Assets 1.7B
Current Liabilities 8.7B
Accounts Payable 2.5B
Accrued Liabilities 83m
Other Current Liabilities 6.1B
Non-Current Liabilities 13.1B
Long-Term Debt 9.2B
Other Non-Current Liabilities 3.9B
Efficiency

Earnings Waterfall
Merck KGaA

Revenue
21B EUR
Cost of Revenue
-8.4B EUR
Gross Profit
12.6B EUR
Operating Expenses
-8.4B EUR
Operating Income
4.2B EUR
Other Expenses
-1.4B EUR
Net Income
2.8B EUR

Free Cash Flow Analysis
Merck KGaA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

MRK Profitability Score
Profitability Due Diligence

Merck KGaA's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive 3-Year Average ROE
57/100
Profitability
Score

Merck KGaA's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

MRK Solvency Score
Solvency Due Diligence

Merck KGaA's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

Low D/E
High Altman Z-Score
Long-Term Solvency
Short-Term Solvency
58/100
Solvency
Score

Merck KGaA's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MRK Price Targets Summary
Merck KGaA

Wall Street analysts forecast MRK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRK is 185.58 EUR with a low forecast of 156.55 EUR and a high forecast of 220.5 EUR.

Lowest
Price Target
156.55 EUR
7% Upside
Average
Price Target
185.58 EUR
26% Upside
Highest
Price Target
220.5 EUR
50% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

MRK Price
Merck KGaA

1M 1M
-6%
6M 6M
+1%
1Y 1Y
-9%
3Y 3Y
+3%
5Y 5Y
+68%
10Y 10Y
+182%
Annual Price Range
146.75
52w Low
135.45
52w High
170.5
Price Metrics
Average Annual Return 22.94%
Standard Deviation of Annual Returns 32.51%
Max Drawdown -39%
Shares Statistics
Market Capitalization 63.8B EUR
Shares Outstanding 434 777 900
Percentage of Shares Shorted
N/A

MRK Return Decomposition
Main factors of price return

What is price return decomposition?

MRK News

Other Videos

Company Profile

Merck KGaA Logo
Merck KGaA

Country

Germany

Industry

Pharmaceuticals

Market Cap

63.8B EUR

Dividend Yield

1.43%

Description

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. The company is headquartered in Darmstadt, Hessen and currently employs 60,334 full-time employees. The firm operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Electronics business enables digital living and provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.

Contact

HESSEN
Darmstadt
Frankfurter Str. 250
+496151720.0
https://www.merckgroup.com/

IPO

1995-10-20

Employees

60 334

Officers

Chair of Executive Board & CEO
Ms. Belen Garijo Lopez M.D.
CFO & Member of Executive Board
Ms. Helene von Roeder
CEO of Electronics & Member of the Executive Board
Dr. Kai Beckmann
CEO of Healthcare Business & Member of Executive Board
Mr. Peter Guenter
CEO of Life Science Sector & Member of Executive Board
Dr. Matthias J. Heinzel
Chief Compliance Officer
Ms. Barbara Weiland
Show More
Head of the Global HR Business Partner Organization
Mr. Dietmar Eidens
Head of Corporate & Government Relations - Europe
Mr. Frank Gotthardt
Head of Life Science Controlling
Mr. Marc Horn
Head of the Display Materials Business Unit for Performance Materials
Dr. Michael Heckmeier
Show Less

See Also

Discover More
What is the Intrinsic Value of one MRK stock?

The intrinsic value of one MRK stock under the Base Case scenario is 146.43 EUR.

Is MRK stock undervalued or overvalued?

Compared to the current market price of 146.75 EUR, Merck KGaA is Fairly Valued.